Title: A Clinical Study of Risk Factors of Coronary Artery Disease including newer Risk Factors in Elderly Patients
Authors: Dr Shikhar Bajpai, Dr Sucheeth Avanti, Dr T. K. Biswas, Dr Digvijay Shinde
DOI: https://dx.doi.org/10.18535/jmscr/v5i1.50
Abstract
Introduction
Coronary artery disease (CAD) is the result of the accumulation of atheromatous plaques within the walls of the coronary arteries. CAD is one of the most common cause of morbidity and mortality in different communities. WHO has predicted that by 2020 up to three quarters of death in developing countries would result from non-communicable diseases and CAD will top the list of killers. Patients with ischeamic heart disease fall into two large groups: patients with chronic coronary artery disease who most commonly present with stable angina and patients with acute coronary syndromes. Despite advances in diagnosis and management, STEMI continues to be a major public health problem in the industrialized world and is rising in developing countries. The rate for MI rises for both men and women sharply with increasing age, and racial differences exist. It seems likely that changing lifestyles such as high consumption of processed foods rich in saturated fat and a low level of physical activity along with the rising prevalence of obesity and type 2 Diabetes are leading to a progressive increase in the prevalence cardiovascular disease in developing countries. This study will help to find out more about risk factors of the CAD in elder patients.
References
1. Jaychandra et al Risk-Factor Profile for Coronary Artery Disease among Young and Elderly Patients in Andhra Pradesh Heart India, Vol 2 / Issue 1/ Jan-Mar 2014
2. Kasliwal RR, Kulshreshtha A, Agrawal S, Bansal M, Trehan N. Prevalence of cardiovascular risk factors in Indian patients undergoing coronary artery bypass surgery. J Assoc Physicians India 2006;54:371-5.
3. Gupta R. Meta-analysis of hypertension in India. Indian Heart J 1997;49:43-8.
4. Von Eyben FE, Bech J, Madsen J, Efsen F. High prevalence of smoking in young patients with acute myocardial infarction. J R Soc Health 1996;116:153-6.
5. Jörgensen S, Köber L, Ottesen M, Torp-Pedersen C, Videbaek J, Kjøller E. The prognostic importance of smoking status at the time of acute myocardial infarction in 6676 patients. J Cardiovasc Risk 1999;6:23-7.
6. . Pfeffer M, McMurray J, Leizorovicz A, Maggioni AP, Rouleau JL, Van De Werf F, et al. VALIANT investigators. Valsartan in acute myocardial infarction trial (VALIANT): Rationale and design. Am Heart J 2000;140:727-50.
7. Shepard J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): A randomized controlled trial. Lancet 2002;360:1623-30.
8. Beg MA, Siddique MKJ, Abbasi AS, Ahmad N. Atherosclerosis in Karachi . J Pak Med Assoc 1967;17:236-40
9. Khan N. Epidemiology of coronary heart disease in Peshawar. Pakistan Heart J 1973;6:64-9.